{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:15:08Z","timestamp":1785906908462,"version":"3.56.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02474-7","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T14:02:52Z","timestamp":1728914572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The influence of non-cancer-related risk factors on the development of cancer-related lymphedema: a rapid review"],"prefix":"10.1007","volume":"41","author":[{"given":"Nicole L.","family":"Stout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKinzey","family":"Dierkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Oliveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Rockson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electra D.","family":"Paskett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"5","key":"2474_CR1","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1007\/s00520-022-06855-4","volume":"30","author":"Z Huang","year":"2022","unstructured":"Huang Z, Wu S. Acceptance of disability, coping style, perceived social support and quality of life among patients with chronic lymphedema: a cross-sectional study. Support Care Cancer. 2022;30(5):4099\u2013108.","journal-title":"Support Care Cancer"},{"issue":"1","key":"2474_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijrobp.2018.08.036","volume":"103","author":"SG McDuff","year":"2019","unstructured":"McDuff SG, Mina AI, Brunelle CL, et al. Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys. 2019;103(1):62\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"2474_CR3","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.ejso.2020.01.033","volume":"46","author":"M Yoshihara","year":"2020","unstructured":"Yoshihara M, Shimono R, Tsuru S, et al. Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: a multi-institutional retrospective study. Eur J Surg Oncol. 2020;46(7):1334\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2020.01.033.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"2474_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijrobp.2009.01.024","volume":"76","author":"AdV Bar","year":"2010","unstructured":"Bar AdV, Cheville A, Solin LJ, Dutta P, Both S, Harris EE. Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2010;76(1):85\u201390. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.01.024.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2474_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.apmr.2015.01.014","volume":"96","author":"N Gebruers","year":"2015","unstructured":"Gebruers N, Verbelen H, De Vrieze T, Coeck D, Tjalma W. Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review. Arch Phys Med Rehabil. 2015;96(6):1131\u20139. https:\/\/doi.org\/10.1016\/j.apmr.2015.01.014.","journal-title":"Arch Phys Med Rehabil"},{"issue":"8 Suppl","key":"2474_CR6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/cncr.27476","volume":"118","author":"NL Stout","year":"2012","unstructured":"Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(8 Suppl):2191\u2013200. https:\/\/doi.org\/10.1002\/cncr.27476.","journal-title":"Cancer"},{"issue":"40","key":"2474_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_280471","volume":"40","author":"SA McLaughlin","year":"2020","unstructured":"McLaughlin SA, Stout NL, Schaverien MV. Avoiding the swell: advances in lymphedema prevention, detection, and management. Am Soc Clin Oncol Educ Book. 2020;40(40):1\u201310. https:\/\/doi.org\/10.1200\/EDBK_280471.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"21","key":"2474_CR8","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1200\/JCO.2007.14.4899","volume":"26","author":"SC Hayes","year":"2008","unstructured":"Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536\u201342. https:\/\/doi.org\/10.1200\/JCO.2007.14.4899.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2474_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/archsurg.2010.231","volume":"145","author":"ML Kwan","year":"2010","unstructured":"Kwan ML, Darbinian J, Schmitz KH, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg. 2010;145(11):1055\u201363. https:\/\/doi.org\/10.1001\/archsurg.2010.231.","journal-title":"Arch Surg"},{"issue":"22","key":"2474_CR10","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1002\/cncr.25458","volume":"116","author":"JN Cormier","year":"2010","unstructured":"Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116(22):5138\u201349. https:\/\/doi.org\/10.1002\/cncr.25458.","journal-title":"Cancer"},{"issue":"11","key":"2474_CR11","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1055-9965.EPI-09-1245","volume":"19","author":"SA Norman","year":"2010","unstructured":"Norman SA, Localio AR, Kallan MJ, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev. 2010;19(11):2734\u201346. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-1245.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2474_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ygyno.2010.06.018","volume":"119","author":"Y Todo","year":"2010","unstructured":"Todo Y, Yamamoto R, Minobe S, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119(1):60\u20134. https:\/\/doi.org\/10.1016\/j.ygyno.2010.06.018.","journal-title":"Gynecol Oncol"},{"issue":"30","key":"2474_CR13","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2012.41.8574","volume":"30","author":"ED Paskett","year":"2012","unstructured":"Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30(30):3726\u201333. https:\/\/doi.org\/10.1200\/JCO.2012.41.8574.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2474_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/PRS.0b013e318277870f","volume":"131","author":"S Akita","year":"2013","unstructured":"Akita S, Mitsukawa N, Rikihisa N, et al. Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer. Plast Reconstr Surg. 2013;131(2):283\u201390. https:\/\/doi.org\/10.1097\/PRS.0b013e318277870f.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2474_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ygyno.2014.11.006","volume":"136","author":"VL Beesley","year":"2015","unstructured":"Beesley VL, Rowlands IJ, Hayes SC, et al. Incidence, risk factors and estimates of a woman\u2019s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. Gynecol Oncol. 2015;136(1):87\u201393.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2474_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3322\/caac.21253","volume":"65","author":"SF Shaitelman","year":"2015","unstructured":"Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65(1):55\u201381. https:\/\/doi.org\/10.3322\/caac.21253.","journal-title":"CA Cancer J Clin"},{"key":"2474_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225667","author":"A Clinckaert","year":"2022","unstructured":"Clinckaert A, Callens K, Cooreman A, et al. The prevalence of lower limb and genital lymphedema after prostate cancer treatment: a systematic review. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14225667.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2474_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s12282-021-01263-8","volume":"28","author":"Y Lin","year":"2021","unstructured":"Lin Y, Xu Y, Wang C, et al. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis. Breast Cancer. 2021;28(6):1261\u201372. https:\/\/doi.org\/10.1007\/s12282-021-01263-8.","journal-title":"Breast Cancer"},{"issue":"11","key":"2474_CR19","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/ijgc-2020-001682","volume":"30","author":"AF Bona","year":"2020","unstructured":"Bona AF, Ferreira KR, Carvalho RBM, Thuler LCS, Bergmann A. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review. Int J Gynecol Cancer. 2020;30(11):1697\u2013704. https:\/\/doi.org\/10.1136\/ijgc-2020-001682.","journal-title":"Int J Gynecol Cancer"},{"issue":"3 Suppl 3","key":"2474_CR20","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1097\/sap.0000000000003107","volume":"88","author":"AS Kuruvilla","year":"2022","unstructured":"Kuruvilla AS, Krajewski A, Li X, et al. Risk factors associated with postmastectomy breast cancer lymphedema: a multicenter retrospective analysis. Ann Plast Surg. 2022;88(3 Suppl 3):S239\u201345. https:\/\/doi.org\/10.1097\/sap.0000000000003107.","journal-title":"Ann Plast Surg"},{"issue":"6","key":"2474_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00520-011-1089-9","volume":"19","author":"SH Ridner","year":"2011","unstructured":"Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer. 2011;19(6):853\u20137. https:\/\/doi.org\/10.1007\/s00520-011-1089-9.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2474_CR22","doi-asserted-by":"publisher","first-page":"e760","DOI":"10.1002\/ctm2.760","volume":"12","author":"SG Rockson","year":"2022","unstructured":"Rockson SG, Zhou X, Zhao L, et al. Exploring disease interrelationships in patients with lymphatic disorders: a single center retrospective experience. Clin Transl Med. 2022;12(4):e760.","journal-title":"Clin Transl Med"},{"key":"2474_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/641818","author":"H Shahpar","year":"2013","unstructured":"Shahpar H, Atieh A, Maryam A, et al. Risk factors of lymph edema in breast cancer patients. Int J Breast Cancer. 2013. https:\/\/doi.org\/10.1155\/2013\/641818.","journal-title":"Int J Breast Cancer"},{"issue":"24","key":"2474_CR24","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1001\/jama.2010.1837","volume":"304","author":"KH Schmitz","year":"2010","unstructured":"Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304(24):2699\u2013705. https:\/\/doi.org\/10.1001\/jama.2010.1837.","journal-title":"JAMA"},{"key":"2474_CR25","unstructured":"World Health Organization. Operational framework for monitoring social determinants of health equity. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240088320#:~:text=Download,(4.1%20MB). Accessed 30 Mar 2024."},{"key":"2474_CR26","unstructured":"Centers for Disease Control and Prevention. About Social Determinants of Health (SDOH). https:\/\/www.cdc.gov\/socialdeterminants\/about.html. Accessed 15 Oct 2022."},{"key":"2474_CR27","doi-asserted-by":"publisher","first-page":"107327482110119","DOI":"10.1177\/10732748211011956","volume":"28","author":"N Afshar","year":"2021","unstructured":"Afshar N, English DR, Milne RL. Factors explaining socio-economic inequalities in cancer survival: a systematic review. Cancer Control. 2021;28:10732748211011956. https:\/\/doi.org\/10.1177\/10732748211011956.","journal-title":"Cancer Control"},{"issue":"6","key":"2474_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11912-023-01396-3","volume":"25","author":"E Gupta","year":"2023","unstructured":"Gupta E, Mitchell CH, Ngo-Huang A, Manne R, Stout NL. Addressing social determinants of health to reduce disparities among individuals with cancer: insights for rehabilitation professionals. Curr Oncol Rep. 2023;25(6):659\u201369.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"2474_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/NNR.0000000000000636","volume":"72","author":"TA Badger","year":"2023","unstructured":"Badger TA, Segrin C, Crane TE, et al. Social determinants of health and symptom burden during cancer treatment. Nurs Res. 2023;72(2):103\u201313.","journal-title":"Nurs Res"},{"issue":"3","key":"2474_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejon.2011.02.005","volume":"15","author":"SG Brearley","year":"2011","unstructured":"Brearley SG, Stamataki Z, Addington-Hall J, et al. The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs. 2011;15(3):204\u201312. https:\/\/doi.org\/10.1016\/j.ejon.2011.02.005.","journal-title":"Eur J Oncol Nurs"},{"issue":"10","key":"2474_CR31","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1080\/09638288.2020.1820587","volume":"44","author":"L Fettes","year":"2022","unstructured":"Fettes L, Neo J, Ashford S, Higginson IJ, Maddocks M. Trajectories of disability in activities of daily living in advanced cancer or respiratory disease: a systematic review. Disabil Rehabil. 2022;44(10):1790\u2013801.","journal-title":"Disabil Rehabil"},{"key":"2474_CR32","doi-asserted-by":"publisher","first-page":"8241710","DOI":"10.1155\/2016\/8241710","volume":"2016","author":"LT Dean","year":"2016","unstructured":"Dean LT, Kumar A, Kim T, et al. Race or resource? BMI, race, and other social factors as risk factors for interlimb differences among overweight breast cancer survivors with lymphedema. J Obes. 2016;2016:8241710. https:\/\/doi.org\/10.1155\/2016\/8241710.","journal-title":"J Obes"},{"issue":"1","key":"2474_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12961-016-0155-7","volume":"14","author":"MM Haby","year":"2016","unstructured":"Haby MM, Chapman E, Clark R, Barreto J, Reveiz L, Lavis JN. What are the best methodologies for rapid reviews of the research evidence for evidence-informed decision making in health policy and practice: a rapid review. Health Res Policy Sys. 2016;14(1):83. https:\/\/doi.org\/10.1186\/s12961-016-0155-7.","journal-title":"Health Res Policy Sys"},{"issue":"12","key":"2474_CR34","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1002\/cncr.32860","volume":"126","author":"NL Stout","year":"2020","unstructured":"Stout NL, Brown JC, Schwartz AL, et al. An exercise oncology clinical pathway: screening and referral for personalized interventions. Cancer. 2020;126(12):2750\u20138. https:\/\/doi.org\/10.1002\/cncr.32860.","journal-title":"Cancer"},{"issue":"3","key":"2474_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ptj\/pzaa002","volume":"100","author":"AM Flores","year":"2020","unstructured":"Flores AM, Nelson J, Sowles L, et al. Lymphedema signs, symptoms, and diagnosis in women who are in minority and low-income groups and have survived breast cancer. Phys Ther. 2020;100(3):487\u201399. https:\/\/doi.org\/10.1093\/ptj\/pzaa002.","journal-title":"Phys Ther"},{"issue":"1","key":"2474_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-016-3913-x","volume":"159","author":"ML Kwan","year":"2016","unstructured":"Kwan ML, Yao S, Lee VS, et al. Race\/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the pathways study. Breast Cancer Res Treat. 2016;159(1):119\u201329. https:\/\/doi.org\/10.1007\/s10549-016-3913-x.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"2474_CR37","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","volume":"8","author":"G Montagna","year":"2022","unstructured":"Montagna G, Zhang J, Sevilimedu V, et al. Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema. JAMA Oncol. 2022;8(8):1195\u2013200. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1628.","journal-title":"JAMA Oncol"},{"issue":"2","key":"2474_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10549-021-06439-6","volume":"191","author":"KA Nyrop","year":"2022","unstructured":"Nyrop KA, Damone EM, Deal AM, et al. Patient-reported treatment toxicity and adverse events in black and white women receiving chemotherapy for early breast cancer. Breast Cancer Res Treat. 2022;191(2):409\u201322. https:\/\/doi.org\/10.1007\/s10549-021-06439-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2474_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/prs.0000000000009761","volume":"151","author":"A Shakir","year":"2023","unstructured":"Shakir A, Coalson E, Beederman M, Froimson JR, Chang DW. Health disparities in patients seeking physiological surgical treatment for lymphedema. Plast Reconstr Surg. 2023;151(1):217\u201324. https:\/\/doi.org\/10.1097\/prs.0000000000009761.","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"2474_CR40","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/jamasurg.2023.2414","volume":"158","author":"DH Rochlin","year":"2023","unstructured":"Rochlin DH, Barrio AV, McLaughlin S, et al. Feasibility and clinical utility of prediction models for breast cancer-related lymphedema incorporating racial differences in disease incidence. JAMA Surg. 2023;158(9):954\u201364. https:\/\/doi.org\/10.1001\/jamasurg.2023.2414.","journal-title":"JAMA Surg"},{"issue":"23","key":"2474_CR41","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1002\/cncr.34489","volume":"128","author":"Y Ren","year":"2022","unstructured":"Ren Y, Kebede MA, Ogunleye AA, et al. Burden of lymphedema in long-term breast cancer survivors by race and age. Cancer. 2022;128(23):4119\u201328. https:\/\/doi.org\/10.1002\/cncr.34489.","journal-title":"Cancer"},{"issue":"4","key":"2474_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s13058-014-0414-x","volume":"16","author":"K Togawa","year":"2014","unstructured":"Togawa K, Ma H, Sullivan-Halley J, et al. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res. 2014;16(4):414. https:\/\/doi.org\/10.1186\/s13058-014-0414-x.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2474_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.clbc.2022.04.003","volume":"22","author":"M Sayan","year":"2022","unstructured":"Sayan M, Kilic SS, Vergalasova I, et al. Risk factors for the development of clinical and subclinical lymphedema detected by bioimpedance spectroscopy. Clin Breast Cancer. 2022;22(6):553\u20139. https:\/\/doi.org\/10.1016\/j.clbc.2022.04.003.","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"2474_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00520-022-07508-2","volume":"31","author":"A Shen","year":"2022","unstructured":"Shen A, Lu Q, Fu X, et al. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies. Support Care Cancer. 2022;31(1):18. https:\/\/doi.org\/10.1007\/s00520-022-07508-2.","journal-title":"Support Care Cancer"},{"issue":"6","key":"2474_CR45","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/cncr.31873","volume":"125","author":"LA Koelmeyer","year":"2019","unstructured":"Koelmeyer LA, Borotkanics RJ, Alcorso J, et al. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care. Cancer. 2019;125(6):854\u201362. https:\/\/doi.org\/10.1002\/cncr.31873.","journal-title":"Cancer"},{"issue":"12","key":"2474_CR46","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809\u201319. https:\/\/doi.org\/10.1002\/cncr.23494.","journal-title":"Cancer"},{"issue":"8","key":"2474_CR47","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00520-011-1285-7","volume":"20","author":"AJ Morehead-Gee","year":"2012","unstructured":"Morehead-Gee AJ, Pfalzer L, Levy E, et al. Racial disparities in physical and functional domains in women with breast cancer. Support Care Cancer. 2012;20(8):1839\u201347. https:\/\/doi.org\/10.1007\/s00520-011-1285-7.","journal-title":"Support Care Cancer"},{"issue":"3","key":"2474_CR48","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1016\/j.ijrobp.2012.04.013","volume":"84","author":"J Deng","year":"2012","unstructured":"Deng J, Ridner SH, Dietrich MS, et al. Factors associated with external and internal lymphedema in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;84(3):e319\u201328. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.04.013.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2474_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10549-008-9940-5","volume":"113","author":"KA Meeske","year":"2009","unstructured":"Meeske KA, Sullivan-Halley J, Smith AW, et al. Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat. 2009;113:383\u201391.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2474_CR50","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.1188\/20.ONF.E161-E170","volume":"47","author":"JF Ding","year":"2020","unstructured":"Ding JF. Prospective surveillance and risk reduction of cancer treatment-related lymphedema: systematic review and meta-analysis. Oncol Nurs Forum. 2020;47(5):E161\u201370.","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"2474_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12962-023-00455-7","volume":"21","author":"P Karaca-Mandic","year":"2023","unstructured":"Karaca-Mandic P, Solid CA, Armer JM, Skoracki R, Campione E, Rockson SG. Lymphedema self-care: economic cost savings and opportunities to improve adherence. Cost Eff Resour Alloc. 2023;21(1):47.","journal-title":"Cost Eff Resour Alloc"},{"key":"2474_CR52","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7104","author":"SM Koroukian","year":"2024","unstructured":"Koroukian SM, Dong W, Albert JM, et al. Treatment patterns and survival outcomes in patients with breast cancer on medicaid, pre- and post-expansion. J Natl Compr Canc Netw. 2024. https:\/\/doi.org\/10.6004\/jnccn.2023.7104.","journal-title":"J Natl Compr Canc Netw"},{"key":"2474_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9111515","author":"M Byun","year":"2021","unstructured":"Byun M, Kim E, Ahn H. Factors contributing to poor self-rated health in older adults with lower income. Healthcare (Basel). 2021. https:\/\/doi.org\/10.3390\/healthcare9111515.","journal-title":"Healthcare (Basel)"},{"issue":"6","key":"2474_CR54","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/SLA.0000000000005455","volume":"277","author":"MV Papageorge","year":"2023","unstructured":"Papageorge MV, Woods AP, de Geus SW, et al. The persistence of poverty and its impact on cancer diagnosis, treatment and survival. Ann Surg. 2023;277(6):995\u20131001.","journal-title":"Ann Surg"},{"issue":"3","key":"2474_CR55","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ijc.30087","volume":"139","author":"FP Boscoe","year":"2016","unstructured":"Boscoe FP, Henry KA, Sherman RL, Johnson CJ. The relationship between cancer incidence, stage and poverty in the United States. Int J Cancer. 2016;139(3):607\u201312.","journal-title":"Int J Cancer"},{"issue":"6","key":"2474_CR56","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00520-023-07800-9","volume":"31","author":"J Bian","year":"2023","unstructured":"Bian J, Shen A, Yang W, Zhang L, Qiang W. Financial toxicity experienced by patients with breast cancer-related lymphedema: a systematic review. Support Care Cancer. 2023;31(6):354.","journal-title":"Support Care Cancer"},{"key":"2474_CR57","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00520-018-4418-4","volume":"27","author":"LT Dean","year":"2019","unstructured":"Dean LT, Moss SL, Ransome Y, et al. \u201cIt still affects our economic situation\u201d: long-term economic burden of breast cancer and lymphedema. Support Care Cancer. 2019;27:1697\u2013708.","journal-title":"Support Care Cancer"},{"issue":"6","key":"2474_CR58","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/pon.4239","volume":"26","author":"J Boyages","year":"2017","unstructured":"Boyages J, Xu Y, Kalfa S, et al. Financial cost of lymphedema borne by women with breast cancer. Psychooncology. 2017;26(6):849\u201355.","journal-title":"Psychooncology"},{"issue":"4","key":"2474_CR59","doi-asserted-by":"publisher","first-page":"181235","DOI":"10.1001\/jamanetworkopen.2018.1235","volume":"1","author":"JM Unger","year":"2018","unstructured":"Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL. Geographic distribution and survival outcomes for rural patients with cancer treated in clinical trials. JAMA Netw Open. 2018;1(4):181235. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.1235.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2474_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10916-017-0850-0","volume":"41","author":"Y Xu","year":"2017","unstructured":"Xu Y, Fu C, Onega T, Shi X, Wang F. Disparities in geographic accessibility of national cancer institute cancer centers in the United States. J Med Syst. 2017;41(12):203. https:\/\/doi.org\/10.1007\/s10916-017-0850-0.","journal-title":"J Med Syst"},{"key":"2474_CR61","doi-asserted-by":"publisher","first-page":"114696","DOI":"10.1016\/j.socscimed.2021.114696","volume":"294","author":"EK Lee","year":"2022","unstructured":"Lee EK, Donley G, Ciesielski TH, et al. Health outcomes in redlined versus non-redlined neighborhoods: a systematic review and meta-analysis. Soc Sci Med. 2022;294:114696. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114696.","journal-title":"Soc Sci Med"},{"issue":"5","key":"2474_CR62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00520-024-08495-2","volume":"32","author":"Y-R Hong","year":"2024","unstructured":"Hong Y-R, Wang R, Case S, Jo A, Turner K, Ross KM. Association of food insecurity with overall and disease-specific mortality among cancer survivors in the US. Support Care Cancer. 2024;32(5):309.","journal-title":"Support Care Cancer"},{"issue":"13","key":"2474_CR63","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.3390\/nu14132723","volume":"14","author":"CA Parks","year":"2022","unstructured":"Parks CA, Carpenter LR, Sullivan KR, et al. A scoping review of food insecurity and related factors among cancer survivors. Nutrients. 2022;14(13):2723.","journal-title":"Nutrients"},{"issue":"11","key":"2474_CR64","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.annepidem.2017.10.002","volume":"27","author":"WE Zahnd","year":"2017","unstructured":"Zahnd WE, McLafferty SL. Contextual effects and cancer outcomes in the United States: a systematic review of characteristics in multilevel analyses. Ann Epidemiol. 2017;27(11):739-48.e3. https:\/\/doi.org\/10.1016\/j.annepidem.2017.10.002.","journal-title":"Ann Epidemiol"},{"issue":"1","key":"2474_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21586","volume":"70","author":"KI Alcaraz","year":"2020","unstructured":"Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31\u201346.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2474_CR66","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2105\/ajph.2006.102525","volume":"98","author":"RB Warnecke","year":"2008","unstructured":"Warnecke RB, Oh A, Breen N, et al. Approaching health disparities from a population perspective: the national institutes of health centers for population health and health disparities. Am J Public Health. 2008;98(9):1608\u201315. https:\/\/doi.org\/10.2105\/ajph.2006.102525.","journal-title":"Am J Public Health"},{"issue":"4","key":"2474_CR67","doi-asserted-by":"publisher","first-page":"104955","DOI":"10.1016\/j.nurpra.2024.104955","volume":"20","author":"S Lynch","year":"2024","unstructured":"Lynch S, Street NW, Sharpe L, Kellish A. Social determinants of health screening: primary care PRAPARE tool implementation. J Nurse Pract. 2024;20(4):104955.","journal-title":"J Nurse Pract"},{"issue":"1","key":"2474_CR68","doi-asserted-by":"publisher","first-page":"8815","DOI":"10.1038\/s41598-024-57410-6","volume":"14","author":"S Tesfaye","year":"2024","unstructured":"Tesfaye S, Cronin RM, Lopez-Class M, et al. Measuring social determinants of health in the All of Us research program. Sci Rep. 2024;14(1):8815.","journal-title":"Sci Rep"},{"issue":"1","key":"2474_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40985-018-0094-7","volume":"39","author":"A Andermann","year":"2018","unstructured":"Andermann A. Screening for social determinants of health in clinical care: moving from the margins to the mainstream. Public Health Rev. 2018;39(1):19. https:\/\/doi.org\/10.1186\/s40985-018-0094-7.","journal-title":"Public Health Rev"},{"issue":"1","key":"2474_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000510696","volume":"90","author":"J Guidi","year":"2020","unstructured":"Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2020;90(1):11\u201327. https:\/\/doi.org\/10.1159\/000510696.","journal-title":"Psychother Psychosom"},{"issue":"5","key":"2474_CR71","doi-asserted-by":"publisher","first-page":"e2313989","DOI":"10.1001\/jamanetworkopen.2023.13989","volume":"6","author":"S Obeng-Gyasi","year":"2023","unstructured":"Obeng-Gyasi S, Elsaid MI, Lu Y, et al. Association of allostatic load with all-cause mortality in patients with breast cancer. JAMA Netw Open. 2023;6(5):e2313989.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2474_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41408-022-00648-y","volume":"12","author":"S Obeng-Gyasi","year":"2022","unstructured":"Obeng-Gyasi S, Graham N, Kumar S, et al. Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients. Blood Cancer J. 2022;12(4):53.","journal-title":"Blood Cancer J"},{"issue":"1","key":"2474_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41523-024-00654-2","volume":"10","author":"J Chen","year":"2024","unstructured":"Chen J, Elsaid MI, Handley D, et al. Allostatic load as a predictor of postoperative complications in patients with breast cancer. NPJ Breast Cancer. 2024;10(1):44.","journal-title":"NPJ Breast Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02474-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02474-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02474-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:16:34Z","timestamp":1731474994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02474-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":73,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["2474"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02474-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work was a review of existing literature and exempt from ethics review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors provide consent to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"274"}}